The Importance of the CALLY Index as a Non-Invasive Prognostic Biomarker in SARS-CoV-2 Infected Patients: An Analytical Study CALLY Index in SARS-CoV-2 Infection
Article Sidebar
Main Article Content
Abstract
Objective: To test the ability of the C-reactive protein-albumin-lymphocyte (CALLY) index to predict in-hospital mortality in hospitalized SARS-CoV-2-infected patients.
Material and Methods: The present study was a retrospective, single-center study. The study population consisted of inpatients who tested positive for the reverse transcription-polymerase chain reaction test for SARS-CoV-2 between January 1, 2023, and April 15, 2023. The demographic data of the patients, vital parameters, the presence of respiratory symptoms, comorbidities, laboratory findings, and in-hospital mortality were recorded. The ability of the CALLY index to predict in-hospital mortality was tested with a receiver operating characteristic analysis and odds ratios.
Results: The study population consisted of 170 inpatients. The CALLY index was significantly lower in survivors [6.5 (2.8-14.0) vs 2.0 (1.1-5.7) p< 0.001] (Mann-Whitney U test). The area under the curve for the CALLY index, C-reactive protein, albumin, and lymphocyte count were 0.700, 0.670, 0.660, and 0.630, respectively. At a cut-off value of 2.724, the CALLY index had a sensitivity of 76.15% and a specificity of 62.50%. A CALLY index below 2.724 increased the risk of in-hospital mortality by 5.32 times. The risk of in-hospital mortality was increased 4.02 times by a CRP above 152.13 mg/dL, 4.07 times by an albumin value below 33.55 g/dL, 3.84 times by a lymphocyte count below 0.58 103/µL, and 5.32 times by a CALLY index below 2.724.
Conclusion: The CALLY index is a predictor of in-hospital mortality among hospitalized SARS-CoV-2-infected patients. This index also showed a superior predictive ability for in-hospital mortality than C-reactive protein, albumin, or lymphocyte count alone.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-07-06
Published 2023-07-08
References
Hassan FE, Kadah AM, AlShareef EM, Nukaly HY, Al-Fadhel JA, AlHartani MM, et al The interplay between severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and the hypothalamic and endocrinal disorders: A Mini-review. Egypt J Immunol. 2023 Jan;30(1):73-86.
Akça HŞ, Algın A, Özdemir S, Sevimli H, Kokulu K, Eroğlu SE. Comparison of the efficacy of PSI, CURB-65, CALL and BCRSS in predicting prognosis and mortality in COVID-19 patients. J Exp Clin Med. 2021; 38(4): 434-43. doi: 10.52142/omujecm.38.4.6.
Abuzer Ö. Evaluation of Short-Term Mortality Prediction Using Initial Lactate and NEWS+L at Admission in COVID-19 Patients. Disaster Med Public Health Prep. 2023 Jan 3;17:e333. doi: 10.1017/dmp.2022.299.
Englisch CN, Tschernig T, Flockerzi F, Meier C, Bohle RM. Lesions in the lungs of fatal corona virus disease Covid-19. Ann Anat. 2021 Mar;234:151657. doi: 10.1016/j.aanat.2020.151657.
Milross L, Majo J, Pulle J, Hoggard S, Cooper N, Hunter B, et al. The trajectory of COVID-19 cardiopulmonary disease: insights from an autopsy study of community-based, pre-hospital deaths. ERJ Open Res. 2022 Dec 27;8(4):00303-2022. doi: 10.1183/23120541.00303-2022.
Ozdemir S, Eroğlu SE, Algın A, Akca HS, Ozkan A, Pala E, et al. Analysis of laboratory parameters in patients with COVID-19: Experiences from a pandemic hospital. Ann Clin Anal Med. 2021;12 (Supp 4):518-523. https://doi.org/10.4328/ACAM.20678.
Özkan A, İslam MM, Akça HS, Eroğlu SE, Aksel G. Effect of the prognostic nutritional index and systemic immune-inflammatory index in predicting short-term mortality in geriatric patients with SARS-CoV-2 infection.. Eur J Clin Exp Med. 2022;20(4):399–403. doi:10.15584/ejcem.2022.4.3.
Müller L, Hahn F, Mähringer-Kunz A, Stoehr F, Gairing SJ, Michel M, et al. Immunonutritive Scoring for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Evaluation of the CALLY Index. Cancers (Basel). 2021 Oct 7;13(19):5018. doi: 10.3390/cancers13195018.
Yang M, Lin SQ, Liu XY, Tang M, Hu CL, Wang ZW, et al. Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study. Front Immunol. 2023 Mar 30;14:1131496. doi: 10.3389/fimmu.2023.1131496.
Tsai YT, Ko CA, Chen HC, Hsu CM, Lai CH, Lee YC, et al. Prognostic Value of CRP-Albumin-Lymphocyte (CALLY) Index in Patients Undergoing Surgery for Oral Cavity Cancer. J Cancer. 2022 Jul 27;13(10):3000-3012. doi: 10.7150/jca.74930.
Iida H, Tani M, Komeda K, Nomi T, Matsushima H, Tanaka S, et al. Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma. HPB (Oxford). 2022 Jan;24(1):101-115. doi: 10.1016/j.hpb.2021.06.414.
Ozdemir S, Algin A. Evaluation of the ability of the C-reactive protein-to-albumin ratio to predict short-term mortality in patients with COVID-19. J Clin Med Kaz. 2021;18(6):35-9. Doi: 10.23950/jcmk/11324.
Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol. 2021 Aug 30;45(4):372-389. doi: 10.3906/biy-2105-37.
Ghizlane EA, Manal M, Abderrahim EK, Abdelilah E, Mohammed M, Rajae A, et al. Lymphopenia in Covid-19: A single center retrospective study of 589 cases. Ann Med Surg (Lond). 2021 Sep;69:102816. doi: 10.1016/j.amsu.2021.102816.
Özdemir S, Algın A. Evaluation of Hematological Parameters in Predicting Short-Term Mortality for COVID 19 Patients with Gastrointestinal Symptoms: A Case-Control Study. J Contemp Med. 2021; 11(5): 710-714. doi: 10.16899/jcm.972664.
Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018 Apr 13;9:754. doi: 10.3389/fimmu.2018.00754.
Ozdemir S, Akça HŞ, Algın A, Eroğlu SE. Can C-reactive protein-to-albumin ratio be a predictor of short-term mortality in community-acquired pneumonia? Ann Clin Anal Med. 2021;12(9):1043-1048. https://doi.org/ 10.4328/ACAM.20576.
Huang I, Pranata R, Lim MA, Oehadian A, Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620937175.
Ceci FM, Ferraguti G, Lucarelli M, Angeloni A, Bonci E, Petrella C, et al. Investigating Biomarkers for COVID-19 Morbidity and Mortality. Curr Top Med Chem. 2023 Feb 22. doi: 10.2174/1568026623666230222094517.
Esposito F, Matthes H, Schad F. Seven COVID-19 Patients Treated with C-Reactive Protein (CRP) Apheresis. J Clin Med. 2022 Apr 1;11(7):1956. doi: 10.3390/jcm11071956.
Soeters PB, Wolfe RR, Shenkin A. Hypoalbuminemia: Pathogenesis and Clinical Significance. JPEN J Parenter Enteral Nutr. 2019 Feb;43(2):181-193. doi: 10.1002/jpen.1451.
Özdemir S, Altunok İ. Comparison of the Predictive Ability of the Blood Urea Nitrogen/Albumin, C-Reactive Protein/Albumin, and Lactate/Albumin Ratios for Short-Term Mortality in SARS-CoV-2-Infected Patients. Avicenna J Med. 2023 Feb 23;13(1):43-48. doi: 10.1055/s-0043-1761471.